Iceland vs North Korea: Number of confirmed cases of tetanus
Iceland
0 Cases
in 2024
North Korea
0 Cases
in 2022
Iceland rank
108th
North Korea rank
108th
Number of confirmed cases of tetanus over time
- Iceland
- North Korea
How they compare
Iceland currently reports 0 Cases against 0 Cases in North Korea, a difference of 0 Cases.
Across all 36 years both countries report, North Korea has been ahead every year.
Iceland ranks 108th and North Korea ranks 108th of 210 countries.
North Korea has averaged higher in every one of the 6 decades both report.
Head to head by decade
| Decade | Iceland | North Korea | Difference | Ahead |
|---|---|---|---|---|
| 1970s | 0 Cases | 256 Cases | 256 Cases | North Korea |
| 1980s | 0 Cases | 546.2 Cases | 546.2 Cases | North Korea |
| 1990s | 0 Cases | 2.2 Cases | 2.2 Cases | North Korea |
| 2000s | 0 Cases | 0 Cases | 0 Cases | — |
| 2010s | 0 Cases | 0 Cases | 0 Cases | — |
| 2020s | 0 Cases | 0 Cases | 0 Cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of confirmed cases of tetanus, Iceland or North Korea?
- Iceland, at 0 Cases against 0 Cases in North Korea as of 2024.
- What is the difference in number of confirmed cases of tetanus between Iceland and North Korea?
- 0 Cases, with Iceland ahead.
- How many years of comparable data are there for Iceland and North Korea?
- 36 years are reported by both, from 1975 to 2022.
- How do Iceland and North Korea rank globally for number of confirmed cases of tetanus?
- Iceland ranks 108th and North Korea ranks 108th of 210 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Number of confirmed cases of tetanus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The annual number of confirmed cases of tetanus. Confirmed numbers underestimate the actual number of tetanus cases, due to limited testing and reporting capacity.